These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18545155)

  • 1. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.
    Viganò A; Zuccotti GV; Pacei M; Erba P; Castelletti E; Giacomet V; Amendola A; Pariani E; Tanzi E; Clerici M
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):289-96. PubMed ID: 18545155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
    Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
    J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
    Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
    Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.
    Kroon FP; Rimmelzwaan GF; Roos MT; Osterhaus AD; Hamann D; Miedema F; van Dissel JT
    AIDS; 1998 Dec; 12(17):F217-23. PubMed ID: 9863863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy.
    Iorio AM; Francisci D; Camilloni B; Stagni G; De Martino M; Toneatto D; Bugarini R; Neri M; Podda A
    Vaccine; 2003 Sep; 21(25-26):3629-37. PubMed ID: 12922092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
    Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.
    Seo YB; Lee J; Song JY; Choi HJ; Cheong HJ; Kim WJ
    Hum Vaccin Immunother; 2016; 12(2):478-84. PubMed ID: 26431466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.
    Parmigiani A; Alcaide ML; Freguja R; Pallikkuth S; Frasca D; Fischl MA; Pahwa S
    PLoS One; 2013; 8(11):e79816. PubMed ID: 24236161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.
    Agrati C; Gioia C; Castilletti C; Lapa D; Berno G; Puro V; Carletti F; Cimini E; Nisii C; Castellino F; Martini F; Capobianchi MR
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1606-16. PubMed ID: 22439734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients.
    Canestri A; Krivine A; Assoumou L; Le Corre M; Rozenberg F; Marcelin AG; Schneider L; Samri A; Carcelain G; Autran B; Katlama C; Guihot A
    AIDS; 2010 Nov; 24(18):2887-9. PubMed ID: 20962616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.
    Yamanaka H; Teruya K; Tanaka M; Kikuchi Y; Takahashi T; Kimura S; Oka S;
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):167-73. PubMed ID: 15905732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children.
    Hainaut M; Ducarme M; Schandene L; Peltier CA; Marissens D; Zissis G; Mascart F; Levy J
    Pediatr Infect Dis J; 2003 Jan; 22(1):62-9. PubMed ID: 12544411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.